Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Fokus Mining Intersects 10 Metres Grading 10.06 G/T At The Galloway Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Bright Minds Biosciences Inc
C.DRUG
Alternate Symbol(s):
DRUG
Healthcare
Biotechnology
Bright Minds Biosciences Inc. is a biotechnology company. The Company is focused on developing transformative treatments for neuropsychiatric disorders, epilepsy, and pain. It has a portfolio of next generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as treatment resistant epilepsy, treatment resistant...
depression, post-traumatic stress disorder (PTSD), and pain. Its pipeline includes BMB-101, BMB-202, and BMB-xxx. BMB-101 is for the treatment of Dravet syndrome and other neurological and neuro-psychiatric disorders. The Company has a portfolio of patented, selective serotonin (5-HT2C, 5-HT2A and 5-HT2C/A-receptor subtypes) agonists that were identified by using high-throughput screening methods in combination with advanced molecular modeling techniques to interrogate the interaction between the drug and its targeted receptors to increase downstream signaling while avoiding off-target effects.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:DRUG)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(4)
•••
Whitman19
X
View Profile
View Bullboard History
Post by
Whitman19
on Jan 10, 2022 2:33am
BMB-101 is all set to hit the clinic in H1’22
Unlike most biotechs developing drugs from naturally occurring psychedelics, Bright Minds is creating novel compounds that retain the therapeutic benefits of psychedelics while minimising side effects
...more
(4)
•••
Whitman19
X
View Profile
View Bullboard History
Post by
Whitman19
on Dec 29, 2021 11:23am
THE MOST POTENT NOVEL PSYCHEDELICS EVER CREATED...
"I would say we have the largest and most advanced psychedelic drug discovery program in the history of the world. That’s over 25 chemists working around the clock developing completely novel
...more
(4)
•••
Whitman19
X
View Profile
View Bullboard History
Post by
Whitman19
on Dec 02, 2021 1:16am
BMB: The next-gen psychedelics to treat neuro conditions
Bright Minds has a portfolio of three patented mechanisms based on serotonin (5-HT) receptors, assessed for indications ranging from depression to chronic pain. The firm also has "
...more
(4)
•••
Whitman19
X
View Profile
View Bullboard History
Comment by
Whitman19
on Nov 03, 2021 10:15am
RE:Bright Minds Bioscience Approved For Nasdaq Listing
This is one of the best news for the psychedelic sector in a long time...Way to go BM
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Nov 03, 2021 8:51am
Bright Minds Bioscience Approved For Nasdaq Listing
There’s another Canadian firm set to trade on the Nasdaq market. Bright Minds Bioscience this morning announced that it has been approved to begin trading on the major big board exchange. https
...more
(1)
•••
amichael
X
View Profile
View Bullboard History
Post by
amichael
on Oct 13, 2021 1:00pm
Dr Gideon Shapiro's podcast interview with Hogan Mullally
Watch Dr Gideo Shapira, VP of discovery discuss the recent, upcoming events at Bright Minds Biosciences and how the success of other firms like Compass Pathways could positively impact the entire
...more
(1)
•••
amichael
X
View Profile
View Bullboard History
Post by
amichael
on Oct 06, 2021 12:39pm
BMB to participate in the LD Investment Conference
Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (CSE: DRUG) (OTCQB: BMBIF), a biotechnology company focused on developing novel drugs for targeted treatment of neuropsychiatric
...more
(4)
•••
Whitman19
X
View Profile
View Bullboard History
Post by
Whitman19
on Oct 05, 2021 7:16am
Ian McDonald's interview with James Hallifax
Watch Ian McDonald, CEO of Bright Minds Biosciences' interview with James Hallifax- Psychedelic Investor YouTube Channel https://www.youtube.com/watch?v=g6BAYc-TsGU
(4)
•••
Whitman19
X
View Profile
View Bullboard History
Comment by
Whitman19
on Oct 04, 2021 1:52pm
RE:Bright Minds Biosciences Proprietary Compound Shows Reductio
Bright Minds looks all set to begin clinical trials on their New Chemical Entity (NCE), BMB-101 sometime in Q1 2022. That's gonna be a big relief to patients suffering from Dravet syndrome, opioid
...more
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Aug 18, 2021 8:55am
Bright Minds Biosciences Proprietary Compound Shows Reductio
Bright Minds Biosciences this morning announced preliminary results from an ongoing study being conducted by the firm. The company has seen efficacy in rodent models of Dravet Syndrome, a form of
...more
(1)
•••
amichael
X
View Profile
View Bullboard History
Post by
amichael
on Jul 26, 2021 1:57pm
Ian McDonald & Gideon Shapiro chat with therealbrom
Watch Brom from theintegrationcompany interview Ian McDonald & Gideon Shapiro https://www.youtube.com/watch?v=SJn032nz2F0Enable GingerCannot connect to Ginger Check your internet connection
...more
(4)
•••
Whitman19
X
View Profile
View Bullboard History
Post by
Whitman19
on Jul 06, 2021 6:10am
BMB- A Search For GW Pharmaceuticals In The Psilocybin Space
Here's an amazing research report from Colin Sullivan making the case for Bright Minds Biosciences, the market size for their drugs, estimated total free and discounted cash flow, NPV and risks
...more
(4)
•••
Whitman19
X
View Profile
View Bullboard History
Post by
Whitman19
on Jul 01, 2021 11:43am
Brom to interview BMB CEO on "The Integration Conversation"
Brom is interviewing Bright Minds CEO Ian McDonald and VP of Discovery Dr. Gideon Shapiro on his podcast, "The Integration Conversation" today. The podcast /youtube channel features the
...more
(1)
•••
amichael
X
View Profile
View Bullboard History
Post by
amichael
on Jun 29, 2021 2:50pm
Paradigm Market Research Inc's top picks
Emerita Resources EMO Bright Minds Biosciences DRUG Deep South Resources DSM Cross River Ventures CRVC For additional info, lookup https://www.paradigmresearch.ca/campaigns/view-campaign
...more
(4)
•••
Whitman19
X
View Profile
View Bullboard History
Post by
Whitman19
on Jun 24, 2021 12:38pm
WATCH Dr GIDEON SHAPIRO'S INTERVIEW ON THE DEEP DIVE
Watch this very informative video to know more about the various serotonin receptors, what causes neurological disorders and how Bright Minds Biosciences (CSE: DRUG, OTCQB: BMBIF) is at the forefront
...more
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Q Precious & Battery Metals Contracts First Class Drilling for Quebec Projects
Why the Tonopah Gold Project is One to Watch
Targeting Nevada and Ontario for the Critical Minerals Supply Chain
Asset Sale Allows Biotech Company to Refocus on the High Value Dermatological Market
Positive PEA for Uranium-Vanadium Deposit After-tax NPV 8%: $227.7 million with IRR: 38.9%
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition